Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Worldviews on Evidence-Based Nursing|July 27, 2025
The Effectiveness of Instant Messaging-Based Interventions on Health Behavior Change: A Systematic Review and Meta-AnalysisTianxue Hou, Mu-Hsing Ho, Huangqianyu Li, et al.
The Lancet Regional Health. Western Pacific|May 9, 2024
Improvements in the health-related quality-of-life benefit of cancer drugs approved in China, 2005-2020: an observational studyLan Zhang, Yichen Zhang, Huangqianyu Li, et al.
Frontiers in Public Health|October 31, 2022
Effect of the full coverage policy of essential medicines on medication adherence: A quasi-experimental study in Taizhou, ChinaZhigang Guo, Zixuan He, Huangqianyu Li, et al.
Frontiers in Pharmacology|June 25, 2024
Cost-effectiveness of durvalumab plus tremelimumab in combination with chemotherapy for the treatment of metastatic non-small-cell lung cancer from the US healthcare sector's and societal perspectivesYena Gan, Fenghao Shi, He Zhu, et al.
Bulletin of the World Health Organization|January 9, 2025
Medicine availability and affordability for paediatric cancers, ChinaLin Bai, Tao Huang, Huangqianyu Li, et al.
Pharmacoepidemiology and Drug Safety|August 2, 2024
Disparity in Guideline-Based Antidiabetic Drugs Prescribing for Type 2 Diabetes Patients in Primary Healthcare Facilities Across China, 2017-2019Mengyuan Fu, Zhiwen Gong, Yuezhen Zhu, et al.
Frontiers in Public Health|July 14, 2022
The Impact of Sanming Healthcare Reform on Antibiotic Appropriate Use in County Hospitals in ChinaLin Hu, Mengyuan Fu, Haishaerjiang Wushouer, et al.
Frontiers in Pharmacology|February 21, 2022
Effects of the Full Coverage Policy of Essential Medicines on Inequality in Medication Adherence: A Longitudinal Study in Taizhou, ChinaZhigang Guo, Liguang Zheng, Mengyuan Fu, et al.
Investigational New Drugs|August 22, 2025
Assessing the risks and benefits of investigational new drugs in adult phase-I oncology trials in China, 2013-2021Zhizhou Liang, Yu Yang, Yichen Zhang, et al.
Journal of Global Health|August 11, 2023
The impact of government reimbursement negotiation on targeted anticancer medicines use and cost in China: A cohort study based on national health insurance dataYu Yang, Yichen Zhang, Anita K Wagner, et al.
Pageof 3